Sequential fluorescence in situ hybridization for the quantification of minimal residual disease in recipient cells after sex-mismatched allogeneic stem cell transplantation

Br J Haematol. 2002 Aug;118(2):349. doi: 10.1046/j.1365-2141.2002.03622.x.
No abstract available

MeSH terms

  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • In Situ Hybridization, Fluorescence / methods
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Neoplasm, Residual / diagnosis
  • Recurrence
  • Transplantation Chimera
  • Transplantation, Homologous